Steven Lane is a Professor in Medicine at the University of Queensland. He is a consultant haematologist and Director of Research in Cancer Care Services at the Royal Brisbane and Women’s Hospital. He is the Head of the Cancer Program at the QIMR Berghofer Medical Research Institute and Group Leader of the Gordon and Jessie Gilmour Leukaemia Research Laboratory. Steven completed his joint clinical and laboratory haematology training at RBWH, Pathology Queensland and the Princess Alexandra Hospital. He completed a postdoctoral research fellowship at the Harvard Medical School. In addition to being Treasurer and Queensland Councillor of the HSANZ, Steven is also Head of the Cancer Theme of Brisbane Diamantina Health Partners, a committee member of the Metro North Research Committee. He is supported by a CSL Centenary Fellowship, the Leukaemia Foundation and NHMRC. He was Cure Cancer Australia’s Researcher of the Year (2016). Steven was the Convenor for Blood 2018 (National annual scientific meeting jointly organised by the HSANZ, ANZSBT and THSANZ).
Dr Hui-Peng (Peng) Lee
Department of Haematology
Flinders Medical Centre
Dr Peng Lee is a Clinical and Laboratory Haematologist at Flinders Medical Centre and SA Pathology in Adelaide. She graduated from the University of Auckland, New Zealand and has dual Fellowship of the Royal Australasian College of Physicians (RACP) and the Royal College of Pathologists of Australasia (RCPA). She moved to Australia from NZ in 2007. Furthermore, she is the Lymphoma Lead Clinician at the South Adelaide Local Health Network, and acts as Principal Investigator for numerous lymphoproliferative clinical trials conducted at Flinders Medical Centre. She was the HSANZ Convenor for the first virtual Blood Conference in 2021. Peng is an active member of the Lymphoma and CLL Working Parties within the Australasian Leukaemia and Lymphoma Group (ALLG). In addition, Peng is a member of Australasian Lymphoma Alliance (ALA), the Haematology Reference Committee for EviQ, Women in Lymphoma (WiL), New Zealand Women in Medicine (NZ WIM) and the SA Statewide Haematology Advanced Training Committee. Outside of haematology, Peng has a young family with a busy husband and two loud children, and runs (for fitness, and terribly). She has a keen interest in travel and is an avid single malt appreciator. She remains in the pursuit of the perfect Work/Life Balance, and she thinks she’s quite nearly achieved it. Nearly.
HONORARY MEMBERSHIP DIRECTOR
Dr Nicholas (Nick) Murphy
Department of Haematology
Royal Hobart Hospital
Dr Nick Murphy is a Clinical and Laboratory Haematologist at the Royal Hobart Hospital, and a Clinical Senior Lecturer at the University of Tasmania. Nick graduated from the University of Melbourne (2002) before undertaking haematology training (FRACP, FRCPA) in Melbourne. Since relocating to Hobart, he has established practices across both Public and Private sectors. He joined as the Tasmanian representative of the Myeloma Australia Scientific Advisory Group (MSAG) in 2017, with Myeloma being his chief area of clinical interest. Nick also serves on the Tasmanian Health Service Statewide Therapeutic/Drug Formulary Committee and is a Member of the Australasian Leukaemia and Lymphoma Group, the American Society of Hematology and the International Myeloma Society. Nick has a young family, which occupies most of his time outside of work.
Dr William (Bill) Renwick
Bill Renwick is currently a Consultant Haematologist for Western Health at Sunshine Hospital, where he is head of service, at Royal Melbourne Hospital, and at Australian Clinical Labs. He has also been, since 2016, the Clinical Services Director, Adult Specialists Clinics, for Western Health. He is also an Honorary Fellow in the Department of Medicine at the University of Melbourne. His chief areas of research interest include Malignant Haematology – Lymphoma, Myeloma, and MDS – and in Benign Haematology – Thalassaemias and Venous Thrombosis. In addition to being a Victorian Councillor on the HSANZ, Bill is Chairman of the Western Health Transfusion Committee, and a member of the Western Health Pharmaceutical Utilisation Committee. From 2012-2015, he was Chairman of the Haematology/Oncology Committee of the Victorian Cooperative Oncology Group.
Dr Xavier Badoux
St George Public and Private Hospital New South Wales
Dr Xavier Badoux is a clinical haematologist with appointments at St George public and St George Private hospitals. He is a conjoint lecturer at the University of NSW. Xavier has a strong research interest in Chronic Lymphocytic Leukaemia (CLL) and lymphoproliferative diseases. He graduated from Harvard University, Massachusetts, followed by his medical degree from the University of Sydney and obtained dual fellowships under the Royal Australasian College of Physicians (FRACP) and Royal College of Pathologists of Australasia (FRCPA). After his speciality training, Xavier completed a clinical fellowship in 2011 at the Leukemia department at MD Anderson Cancer Center in Houston, Texas. He pursued a research interest in novel therapeutic mechanisms in CLL, investigating the immunological changes occurring with immunomodulatory therapy. Since his return to Australia, Xavier maintains a strong interest in lymphoma and leukaemia research. Furthermore, he is the principal investigator in a number of international clinical trials in chronic Lymphocytic leukaemia and lymphoma, exploring the benefits of novel targeted therapies in the treatment of these diseases. He is the author of a number of peer-reviewed original research in high-impact journals.
Assoc Prof Christina Brown
Institute of Haematology
Royal Prince Alfred Hospital
New South Wales
Christina Brown is a Clinical and Laboratory Haematologist at Royal Prince Alfred Hospital in Sydney and a Clinical Associate Professor of Medicine at the University of Sydney. She obtained her medical degree at the University of Sydney, and has a dual fellowship from the Royal Australasian College of Physicians and the Royal College of Pathology of Australasia. Before medical training, she was a medical research scientist with a PhD from London University in B cell autoimmunity. Her subspecialty interests are in malignant haematology and include lymphoma, MDS, AML and the myeloproliferative disorders. Christina has a strong focus in post graduate medical education and is a haematology examiner with the Royal Australasian College of Pathologists. Furthermore, she is the current Coordinator of Advanced Training in Haematology on the Committee for Joint College training within the Royal Australasian College of Physicians.
Dr Benedict (Ben) Carnley
Department of Haematology
Royal Perth Hospital
Dr Benedict Carnley is a consultant haematologist who graduated from the University of Western Australia in 1994 with a Bachelor of Medicine, Bachelor of Surgery. The Royal Australian College of Physicians accepted Dr Carnley as a fellow in 2004 and in 2005 Dr Carnley became a member of the Royal College of Pathologists. Ben is also a Director of the Perth Blood Institute and is an active researcher who has been a co-investigator on over 50 clinical trials. In addition, Ben is currently a consultant haematologist at Haematology West, Royal Perth Hospital, Hollywood Private Hospital and St John of God Hospital and Pathology.
Dr Annette Neylon
Department of Medicine (Dunedin)
University of Otago
Dunedin, New Zealand
Annette Neylon completed training in Haematology in Newcastle upon Tyne in 2003, obtaining fellowships of the Royal College of Physicians and Royal College of Pathologists (UK), as well as completing an MD in the field of Chronic Myeloid Leukaemia. She worked as a Specialist Haematology and Lead of the South of Tyne Haematology Specific Tumour Group of the Northern Cancer Network between 2003 and 2007, before moving to Southern Blood and Cancer Service in Dunedin, Otago as Clinical Lead of Haematology. She was admitted as a Fellow of the Royal Australasian College in 2010. Between 2008 and 2019 she worked as a member of the New Zealand Ministry of Health Haematology Work Group. She has acted as Principal Investigator of several clinical research trials. In addition, Annette was Clinical representative to the South Island NZ DHBs Clinical Operations Advisory Group and since 2018 has been a member of the RACP NZ Joint College Training Sub-Committee for Haematology. Her main areas of interest are in malignant haematology, especially multiple myeloma and lymphoma. When not working, Annette functions as a taxi driver, event organiser and side-line cheerleader for her son.
Dr Meaghan (Meg) Wall
Victorian Clinical Genetic Services
Meaghan Wall is a Haematologist and Genetic Pathologist at VCGS (Victorian Clinical Genetics Services). She studied medicine at Monash University and received her PhD from the University of Melbourne. In addition to being a Victorian Councillor of the HSANZ, Meaghan serves as Cytogeneticist to the Australasian Leukaemia and Lymphoma Group National Blood Cancer Registry. In addition, Meaghan and is a member of the Human Genetics Society of Australasia and the Australasian Society of Diagnostic Genomics. Meaghan’s research encompasses cancer cell biology and cancer genetics, with a focus on haematological malignancies. She has co-authored more than 50 peer-reviewed papers and two book chapters. Meaghan is also actively involved in education and teaching and is a haematology examiner for the Royal Australasian College of Pathologists.
Stephanie Anderson Early Career Representative
Stephanie Anderson is the Early Career
representative for HSANZ. She is currently undertaking a PhD titled ‘Gene
editing to cure Sickle Cell Disease’ at the Australian Centre for Blood
Diseases and is a recipient of the HSANZ New Investigator Scholarship.
Stephanie undertook a Bachelor of Medical Science before graduating from
medicine at the University of Sydney. She has dual Fellowship of the Royal
Australasian College of Physicians and the Royal College of Pathologists of
Australasia. Stephanie is an avid hockey player, and enjoys taking her dog for
walks along St Kilda beach.
Andrew (Andy) Steele President
HSANZ Nurses Group
Andy started working in Oncology upon qualification in 1991 in the UK. His first role in Haematology was 3 years later at Derriford Hospital, Plymouth, and he became Charge nurse there in 1998. In 2000, Andy moved to Kalgoorlie, WA, working in Restorative and Palliative care as a manager and stayed there for 2 years before moving to Perth to work on the Haematology ward, G73. He stayed there for 14 years night and day and then moved to the Haematology Day Ward as Clinical Nurse Specialist and then Manager in 2014. He has been a Nurses Representative for the HSANZ Nurses group WA since 2015 and became vice president of the national nurses group in 2020. Furthermore, he has an interest in Change Theory, presenting several times at Blood Conferences as well as organising and chairing the nurse’s stream of Blood 2019 in Perth. He has obtained a post grad certificate in Leading Great Care.
GENERAL MANAGER and
New South Wales
Valerie Orton is the General Manager and Company Secretary of HSANZ. She obtained her Bachelor of Arts in Psychology and Philosophy from the University of New South Wales and University of California Santa Barbara and Master of Applied Science in Social Ecology from Western Sydney University, Hawkesbury. With a business background, Valerie has operated her consulting business for several years, focussing on coaching and training in ‘soft’ human skills. She has also managed two other Associations – Chief Executive Woman and Sustainable Business Australia. Her book Everyday Resilience – Creating Calm from Chaos is a bestseller (not really!), but it is a good practical book.
She started working with HSANZ in January 2020 and has enjoyed the challenge of bringing the Society into the new decade. While not sitting in front of a computer, she loves walking on the beach or in the mountains, practising her bass guitar and is writing another book.